Literature DB >> 28877919

High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization Study.

Anne Langsted1,2,3, Pia R Kamstrup1,2,3, Børge G Nordestgaard4,2,3,5.   

Abstract

BACKGROUND: The physiological role of lipoprotein(a) is unclear; however, lipoprotein(a) may play a role in hemostasis and wound healing. We tested the hypothesis that high lipoprotein(a) concentrations are associated with low risk of major bleeding in the brain and airways both observationally and causally (from human genetics).
METHODS: We examined 109169 individuals from the Copenhagen City Heart Study and the Copenhagen General Population study, 2 similar prospective studies conducted in the Danish general population. Individuals had information on plasma lipoprotein(a) concentrations (n = 59980), LPA kringle-IV type 2 (KIV-2) number of repeats (n = 98965), and/or LPA single-nucleotide polymorphism rs10455872 associated with high lipoprotein(a) concentrations (n = 109 169), and information on hospital contacts or death due to major bleeding in brain and airways from registers.
RESULTS: Using extreme phenotypes or genotypes, the multifactorially adjusted hazard ratio for major bleeding in the brain and airways was 0.84 (95%CI: 0.71-0.99) for lipoprotein(a), >800 mg/L vs <110 mg/L; 0.83 (0.73-0.96) for KIV-2, <24 vs >35 number of repeats; and 0.89 (0.81-0.97) for rs10455872 carriers (heterozygotes + homozygotes) vs noncarriers. The corresponding hazard ratios were 0.89 (0.82-0.98) for heterozygotes and 0.59 (0.36-0.98) for homozygotes separately vs rs10455872 noncarriers. Also, for a 1 standard deviation higher lipoprotein(a) (= 310 mg/L), the hazard ratio for major bleeding in the brain and airways was 0.95 (95%CI: 0.91-1.00) observationally, 0.89 (0.80-0.98) causally based on LPA KIV-2 number of repeats, and 0.94 (0.87-1.02) causally based on LPA rs10455872.
CONCLUSIONS: High lipoprotein(a) concentrations were associated with lower risk of major bleeding in the brain and airways observationally and causally. This indicates that lipoprotein(a) may play a role in hemostasis and wound healing.
© 2017 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28877919     DOI: 10.1373/clinchem.2017.276931

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment.

Authors:  Lotte C A Stiekema; Erik S G Stroes; Simone L Verweij; Helina Kassahun; Lisa Chen; Scott M Wasserman; Marc S Sabatine; Venkatesh Mani; Zahi A Fayad
Journal:  Eur Heart J       Date:  2019-09-01       Impact factor: 29.983

Review 2.  Advances in lipid-lowering therapy through gene-silencing technologies.

Authors:  Børge G Nordestgaard; Stephen J Nicholls; Anne Langsted; Kausik K Ray; Anne Tybjærg-Hansen
Journal:  Nat Rev Cardiol       Date:  2018-02-08       Impact factor: 32.419

3.  Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.

Authors:  Stephen Burgess; Brian A Ference; James R Staley; Daniel F Freitag; Amy M Mason; Sune F Nielsen; Peter Willeit; Robin Young; Praveen Surendran; Savita Karthikeyan; Thomas R Bolton; James E Peters; Pia R Kamstrup; Anne Tybjærg-Hansen; Marianne Benn; Anne Langsted; Peter Schnohr; Signe Vedel-Krogh; Camilla J Kobylecki; Ian Ford; Chris Packard; Stella Trompet; J Wouter Jukema; Naveed Sattar; Emanuele Di Angelantonio; Danish Saleheen; Joanna M M Howson; Børge G Nordestgaard; Adam S Butterworth; John Danesh
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

Review 4.  Genetic Polymorphisms Associated with Spontaneous Intracerebral Hemorrhage.

Authors:  Yi-Chun Chen; Kuo-Hsuan Chang; Chiung-Mei Chen
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

Review 5.  Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-03-20

6.  Low-density lipoprotein cholesterol levels are positively associated with the risk of endobronchial biopsy-induced refractory hemorrhage in patients with lung cancer.

Authors:  Saibin Wang; Xianqing Hu; Yibin Pan
Journal:  Lipids Health Dis       Date:  2019-11-04       Impact factor: 3.876

7.  Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China.

Authors:  Yanbing Chen; Xiaojiang Zhan; Qing Zhao; Xin Wei; Jun Xiao; Caixia Yan; Wei Zhang
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.